Dr. Manasi Jaiman has served as Aardvark's Chief Medical Officer since September 2024. From October 2022 to March 2024 she was Vice President, Clinical Development and Platform Lead at Vertex Pharmaceuticals (Nasdaq: VRTX), and from 2020 to 2023 she served in various roles at ViaCyte, Inc., including Chief Medical Officer and Vice President of Clinical Development, developing novel cell-therapy approaches. She was previously Senior Medical Director at Covance/LabCorp and, from 2014 to 2020, an attending physician at Harvard Medical School and Massachusetts General Hospital caring for pediatric endocrinology patients, including those with Prader-Willi syndrome. Dr. Jaiman received her M.D. from the Medical University of South Carolina, her M.P.H. from Tulane University, and a B.S. in Psychology from the University of South Carolina Honors College.